Table 2.
Treatment regimens for leprosy as recommended by the World Health Organization.
| Population | Medication | Dose | Duration | |
|---|---|---|---|---|
| Paucibacillary leprosy | Multibacillary leprosy | |||
| Adults | Rifampicin | 600 mg/month | 6 months | 12 months |
| Clofazimine | 300 mg/month + 50 mg/day | 6 months | 12 months | |
| Dapsone | 100 mg/day | 6 months | 12 months | |
| Children (10–14 years) | Rifampicin | 450 mg/month | 6 months | 12 months |
| Clofazimine | 150 mg/month + 50 mg/day | 6 months | 12 months | |
| Dapsone | 50 mg/day | 6 months | 12 months | |
| Children (< 10 years old or < 40 kg) | Rifampicin | 10 mg/kg/month | 6 months | 12 months |
| Clofazimine | 6 mg/kg/month + 1 mg/kg/day |
6 months | 12 months | |
| Dapsone | 2 mg/kg/daily | 6 months | 12 months |